Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

WILLIAM BARRY LEE

Allopathic & Osteopathic Physicians Ophthalmology Cornea and External Diseases Specialist

NPI
1366406787
CMS profile
152779
Location
ATLANTA, GA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$46,842.02

96 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

By paying entity

PY2020 · entire year · sorted by reported total

Page 2 of 2; records 51–96 of 96 matching records. This page contains 46 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

WILLIAM BARRY LEE

NPI 1366406787 · CMS profile ID 152779

Allopathic & Osteopathic Physicians / Ophthalmology / Cornea and External Diseases Specialist

ATLANTA, GA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–96 of 96 matching records. This page contains 46 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1366406787?year=2020&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
WILLIAM BARRY LEE, NPI 1366406787, CMS profile ID 152779. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–96 of 96 matching records. This page contains 46 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1366406787?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). WILLIAM BARRY LEE, NPI 1366406787, CMS profile ID 152779. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–96 of 96 matching records. This page contains 46 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1366406787?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
WILLIAM BARRY LEE, NPI 1366406787, CMS profile ID 152779, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–96 of 96 matching records. This page contains 46 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1366406787?year=2020&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

96 matching records · $46,842.02 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 96 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–96 of 96.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Kala Pharmaceuticals, Inc. $4.8305/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 730020871 CMS
Allergan, Inc. $18.8005/26/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723469145 CMS
Mallinckrodt Hospital Products Inc. $25.6405/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751707267 CMS
Sun Pharmaceutical Industries Inc. $21.9505/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728252067 CMS
Eyevance Pharmaceuticals LLC $500.0005/11/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 753061637 CMS
Kala Pharmaceuticals, Inc. $14.8305/06/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 730020869 CMS
Eyevance Pharmaceuticals LLC $500.0004/30/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 753061635 CMS
EyePoint Pharmaceuticals US, Inc. $105.5603/25/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736584443 CMS
EyePoint Pharmaceuticals US, Inc. $145.3003/25/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736584445 CMS
Sun Pharmaceutical Industries Inc. $3,500.0003/12/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728252149 CMS
Sun Pharmaceutical Industries Inc. $122.6303/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728252151 CMS
Sun Pharmaceutical Industries Inc. $190.9703/12/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728252173 CMS
Sun Pharmaceutical Industries Inc. $3,500.0003/10/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728252145 CMS
Sun Pharmaceutical Industries Inc. $110.0803/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728252147 CMS
Sun Pharmaceutical Industries Inc. $936.8003/10/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728252175 CMS
Sun Pharmaceutical Industries Inc. $82.8303/10/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728252177 CMS
Bausch & Lomb, a division of Bausch Health US, LLC $19.1503/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 737393385 CMS
Bausch & Lomb, a division of Bausch Health US, LLC $3.3203/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 737393387 CMS
Sun Pharmaceutical Industries Inc. $1,500.0002/27/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728252141 CMS
Sun Pharmaceutical Industries Inc. $125.0002/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728252143 CMS
EyePoint Pharmaceuticals US, Inc. $1,200.0002/25/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736582535 CMS
Novartis Pharmaceuticals Corporation $13.4402/25/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 725990191 CMS
Glaukos Corporation $124.5202/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 753305567 CMS
Glaukos Corporation $82.2102/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 753305579 CMS
Mallinckrodt Hospital Products Inc. $23.1702/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751707265 CMS
Akorn, Inc. $23.8102/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 753082375 CMS
EyePoint Pharmaceuticals US, Inc. $3,000.0002/04/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736584447 CMS
Kala Pharmaceuticals, Inc. $15.5002/04/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 730020867 CMS
Ocular Therapeutix, Inc. $1,950.0001/31/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748837469 CMS
Alcon Vision LLC $11.6901/24/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 729622329 CMS
Ocular Therapeutix, Inc. $59.0601/24/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748837467 CMS
EyePoint Pharmaceuticals US, Inc. $31.0001/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736582537 CMS
Kala Pharmaceuticals, Inc. $48.1901/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 730020865 CMS
Dompe US, Inc. $1,800.0001/20/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749842863 CMS
Dompe US, Inc. $78.5501/20/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749842865 CMS
EyePoint Pharmaceuticals US, Inc. $41.0001/19/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736582533 CMS
EyePoint Pharmaceuticals US, Inc. $34.2801/19/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736582539 CMS
Glaukos Corporation $116.4701/19/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 753305417 CMS
Sun Pharmaceutical Industries Inc. $48.8401/19/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728252061 CMS
Novartis Pharmaceuticals Corporation $240.6201/16/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 725990179 CMS
Novartis Pharmaceuticals Corporation $642.5901/16/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 725990181 CMS
Novartis Pharmaceuticals Corporation $5,600.0001/16/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 725990183 CMS
Novartis Pharmaceuticals Corporation $88.9401/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 725990185 CMS
Novartis Pharmaceuticals Corporation $416.8001/16/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 725990187 CMS
Johnson & Johnson Surgical Vision, Inc. $20.1601/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719004307 CMS
Johnson & Johnson Surgical Vision, Inc. $68.0901/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719004315 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $90,160.48 152
PY2020 $46,842.02 96
PY2021 $70,498.48 162
PY2022 $81,899.86 168
PY2023 $80,189.56 145
PY2024 $43,659.95 135
PY2025 $88,076.55 156

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $17,649.00 8
PY2024 Principal investigator $4,677.00 3
PY2023 Principal investigator $962.50 2
PY2022 Principal investigator $20,629.66 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

8 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Oyster Point Pharma, Inc. $1,638.00 10/15/2025 Non-covered Recipient Entity
Eye Consultants of Atlanta PC
A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis No dispute reported 06/30/2026 1238522450
Principal investigator 1 Oyster Point Pharma, Inc. $3,144.60 10/15/2025 Non-covered Recipient Entity
Eye Consultants of Atlanta PC
A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis No dispute reported 06/30/2026 1238522452
Principal investigator 1 Oyster Point Pharma, Inc. $1,611.00 08/14/2025 Non-covered Recipient Entity
Eye Consultants of Atlanta PC
A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis No dispute reported 06/30/2026 1238522448
Principal investigator 1 Oyster Point Pharma, Inc. $1,778.40 06/13/2025 Non-covered Recipient Entity
Eye Consultants of Atlanta PC
A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis No dispute reported 06/30/2026 1238522442
Principal investigator 1 Oyster Point Pharma, Inc. $1,778.40 04/28/2025 Non-covered Recipient Entity
Eye Consultants of Atlanta PC
A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis No dispute reported 06/30/2026 1238522444
Principal investigator 1 Oyster Point Pharma, Inc. $1,724.40 03/19/2025 Non-covered Recipient Entity
Eye Consultants of Atlanta PC
A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis No dispute reported 06/30/2026 1238522440
Principal investigator 1 Oyster Point Pharma, Inc. $1,864.80 02/10/2025 Non-covered Recipient Entity
Eye Consultants of Atlanta PC
A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis No dispute reported 06/30/2026 1238522438
Principal investigator 1 Oyster Point Pharma, Inc. $4,109.40 01/17/2025 Non-covered Recipient Entity
Eye Consultants of Atlanta PC
A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis No dispute reported 06/30/2026 1238522436